Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
Moleculin Biotech disclosed new preclinical pancreatic cancer data on Annamycin, presented at the AACR Conference on Pancreatic Cancer. Findings suggest the drug’s antitumor effect is partly driven by CD8+ T cells, indicating potential to make “cold” tumors more immune-responsive. The results support a possible combina
Moleculin announced new Annamycin data to be presented at AACR and two European scientific meetings in September 2026.Key Highlights:Original SEC Filing: Moleculin Biotech, Inc. [ MBRX ] - 8-K - Sep. 14, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important in…
Moleculin Biotech said it will showcase new annamycin data at the AACR conference on pancreatic cancer and at two European scientific meetings.